Vimarsana
Biggest News Aggregation in the World

Page 42 - Accessed May News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accessed May. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accessed May Today - Breaking & Trending Today

Frontiers | The Impact of COVID-19 Pandemic on Seafood Safety and Human Health - Vimarsana News

Frontiers | The Impact of COVID-19 Pandemic on Seafood Safety and Human Health

The coronavirus disease (COVID-19) pandemic caused several negative impacts on global human health and the world's economy. Food and seafood safety and security were amongst the principal challenges and causes of concern for the food industry and consumers during the spread of this global pandemic. This article focused on the effects of COVID-19 pandemic on potential safety issues with seafood products and their processing methods. Moreover, the potential impacts of coronavirus transmission through seafood on human health were evaluated. The role of authenticity, traceability, and antimicr...

Novartis receives European Commission approval for Tabrecta® for the treatment of METex14 skipping advanced non-small cell lung cancer | Small Molecules - Vimarsana News

Novartis receives European Commission approval for Tabrecta® for the treatment of METex14 skipping advanced non-small cell lung cancer | Small Molecules

Novartis receives European Commission approval for Tabrecta® for the treatment of METex14 skipping advanced non-small cell lung cancer

PROpel Phase III trial positive results of Lynparza plus abiraterone in 1st-line metastatic castration-resistant prostate cancer published in New England Journal of Medicine Evidence - Vimarsana News

PROpel Phase III trial positive results of Lynparza plus abiraterone in 1st-line metastatic castration-resistant prostate cancer published in New England Journal of Medicine Evidence

Results from the PROpel Phase III trial showed that AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone significantly improved radiographic progression-free survival (rPFS) versus abiraterone alone as a 1st-line treatment for patients with metastatic castration-resistant prostate cancer ...

Nine Lives | Humanities | JAMA | JAMA Network - Vimarsana News

Nine Lives | Humanities | JAMA | JAMA Network

In this narrative medicine essay, a family medicine physician describes a favorite patient's infectious exuberance for life persisting through his dementia and

How Feasible is a Robotic Future in Healthcare? - Vimarsana News

How Feasible is a Robotic Future in Healthcare?

The pandemic highlighted the importance of and breadth of robotics applications, shining a light on a potential robotic future in healthcare, which we discuss here.